Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation

Christian E. Oberkofler, Dimitri A. Raptis, Philip C. Müller, Richard X. Sousa da Silva, Kuno Lehmann, Takahiro Ito, Timothy Owen, Joerg Matthias Pollok, Alessandro Parente, Andrea Schlegel, Peregrina Peralta, Erin Winter, Markus Selzner, Margot Fodor, Manuel Maglione, Manuel Jaklitsch, Hugo P. Marques, Mariana Chavez-Villa, Alan Contreras, Philipp KronPeter Lodge, Scott Alford, Abbas Rana, Paolo Magistri, Fabrizio Di Benedetto, Bethany Johnson, Varvara Kirchner, Francis Bauldrick, Karim J. Halazun, Omid Ghamarnedjad, Arianeb Mehrabi, Samanta Teixeira Basto, Eduardo S.M. Fernandes, Jose Paladini, Martin de Santibañes, Sander Florman, Parissa Tabrizian, Philipp Dutkowski, Pierre Alain Clavien, Ronald W. Busuttil, Fady M. Kaldas, Henrik Petrowsky

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences